The natural history of EGFR and EGFRvIII in glioblastoma patients

被引：0
|
作者：
Amy B Heimberger
Dima Suki
David Yang
Weiming Shi
Kenneth Aldape
机构：
[1] The Brain Tumor Center,Department of Neurosurgery
[2] The University of Texas M. D. Anderson Cancer Center,Pathology, The Brain Tumor Center
[3] The University of Texas M. D. Anderson Cancer Center,undefined
来源：
Journal of Translational Medicine | / 3卷
关键词：
Glioma; survival; sub-total resection;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Simultaneous detection of EGFR amplification and EGFRvIII variant using digital PCR-based method in glioblastoma
    Maxime Fontanilles
    Florent Marguet
    Philippe Ruminy
    Carole Basset
    Adrien Noel
    Ludivine Beaussire
    Mathieu Viennot
    Pierre-Julien Viailly
    Kevin Cassinari
    Pascal Chambon
    Doriane Richard
    Cristina Alexandru
    Isabelle Tennevet
    Olivier Langlois
    Frédéric Di Fiore
    Annie Laquerrière
    Florian Clatot
    Nasrin Sarafan-Vasseur
    Acta Neuropathologica Communications, 8
  • [42] EGFRvIII expression defines a distinct subtype of glioblastoma: A study of 268 patients
    Pelloski, CE
    Yung, WA
    Colman, H
    Zhang, L
    Lin, E
    Woo, SY
    Yang, H
    Ledoux, A
    Aldape, KD
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S68 - S68
  • [43] IDENTIFICATION OF EXOSOMAL RNA LEVELS OF EGFRVIII FROM THE SERA OF PATIENTS WITH GLIOBLASTOMA
    Carter, Bob S.
    Hochberg, Fred
    Skog, Johan
    Sahin, Ayguen
    Zhu, Lin Dan
    Lessard, Ryan
    Breakefield, Xandra
    NEURO-ONCOLOGY, 2009, 11 (05) : 604 - 604
  • [44] Phase I study of T cells redirected to EGFRvIII with a chimeric antigen receptor in patients with EGFRvIII plus glioblastoma
    O'Rourke, Donald M.
    Nasrallah, MacLean P.
    Morrissette, Jennifer
    Melenhorst, Jan J.
    Lacey, Simon F.
    Mansfield, Keith
    Martinez-Lage, Maria
    Desai, Arati
    Brem, Steven
    Maloney, Eileen
    Mohan, Suyash
    Wang, Sumei
    Verma, Gaurav
    Navenot, Jean-Marc
    Shen, Angela
    Zheng, Zhaohui
    Levine, Bruce L.
    Okada, Hideho
    June, Carl H.
    Maus, Marcela V.
    CANCER RESEARCH, 2016, 76
  • [45] D2C7-CAR: A NOVEL, DUAL-SPECIFIC CHIMERIC ANTIGEN RECEPTOR T CELL WITH HIGH SPECIFICITY FOR EGFR AND EGFRVIII IMPROVES SURVIVAL IN EGFR/EGFRVIII GLIOBLASTOMA AND EGFR OVER-EXPRESSING MEDULLOBLASTOMA
    Wilson, Zach
    Wilkinson, Daniel
    Ryan, Katherine
    Chandramohan, Vidya
    Bigner, Darrell
    Fecci, Peter
    NEURO-ONCOLOGY, 2023, 25
  • [46] RESISTANCE TO EGFR INHIBITION VIA THE EMERGENCE OF EGFRVIII-INDEPENDENT TUMOR GROWTH-PROMOTING MECHANISMS IN GLIOBLASTOMA
    Wykosky, Jill
    Mukasa, Akitake
    Chin, Lynda
    Cavenee, Webster
    Furnari, Frank
    NEURO-ONCOLOGY, 2010, 12 : 21 - 21
  • [47] Lessons learned from rindopepimut treatment in patients with EGFRvIII-expressing glioblastoma
    Binder, David C.
    Ladomersky, Erik
    Lenzen, Alicia
    Zhai, Lijie
    Lauing, Kristen L.
    Otto-Meyer, Sebastian D.
    Lukas, Rimas V.
    Wainwright, Derek A.
    TRANSLATIONAL CANCER RESEARCH, 2018, 7 : S510 - S513
  • [48] DCA bind to EGFR/EGFRvIII/PDK1 and affect the proliferation and growth in TMZ resistant glioblastoma model
    Velpula, Kiran Kumar
    Sahu, Kamlesh
    Tuszynski, Jack
    Guda, Maheedhara R.
    Asuthkar, Swapna
    Martin, Sarah E.
    Lathia, Justin D.
    Tsung, Andrew J.
    CANCER RESEARCH, 2016, 76
  • [49] Prognostic effect of epidermal growth factor receptor and EGFRvIII in glioblastoma multiforme patients
    Heimberger, AB
    Hlatky, R
    Suki, D
    Yang, D
    Weinberg, J
    Gilbert, M
    Sawaya, R
    Aldape, K
    CLINICAL CANCER RESEARCH, 2005, 11 (04) : 1462 - 1466
  • [50] Prognostic value of MGMT promoter status and EGFRvIII expression in glioblastoma patients.
    Montano, N.
    Banna, G. L.
    Martini, M.
    D'Alessandris, G.
    Cenci, T.
    Giuffrida, D.
    Maira, G.
    De Maria, R.
    Larocca, L.
    Paliini, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345